ClearanceBrief
Recall Z-2046-2018 ยท MQM Bilirubin (Total And Unbound) In The Neonate Test System

Draeger Medical Systems, Inc.

Draeger Jaundice Meter JM-103 The device is intended for use in hospitals, clinics or doctor s offices under a physician s supervision / direction to assist clinicians in monitoring of newborn infants. The device is not intended as a standalone for diagnosis of hyperbilirubinemia. It is to be used in conjunction with other clinical signs and laboratory measurements. The Jaundice Meter is not in

DateJun 7, 2018 (initiated May 15, 2018)
StatusTerminated
ReasonUsers have misinterpreted the display for out of range measurement indicated by the blinking" ---" to mean a zero measurement.
Root causeDevice Design
ActionThe firm, Drager, sent an "Urgent Medical Device Safety Notices" were distributed to customers on 5/15/18. The letter described the product, problem and actions to be taken. The letters instruct customers to perform the following: Enclosed with this letter are label/s and instructions on how and hwere to apply the label onto your device/s. Please make sure that all JM-105/JM-103 devices in your hospital are labeled according to the instructions in a timely manner. Please make sure that in your clinical environment the users are trained in the use of the equipment and the clinical workflow
Quantity10363
DistributionWorldwide Distribution: US (nationwide) including states of: AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY; and countries of: Algeria, Argentin
FDA recordOpen on fda.gov

510(k) clearances named in this recall

K042522JAUNDICE METER, MODEL JM 103
Draeger Medical Infant Care, Inc., Jul 6, 2005